We are live on ! Find out more
NVO

Novo Nordisk
NVO

484 hedge funds and large institutions have $6.59B invested in Novo Nordisk in 2017 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 149 increasing their positions, 176 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 38

51% more call options, than puts

Call options by funds: $45.5M | Put options by funds: $30.1M

38% more funds holding in top 10

Funds holding in top 10: 8 → 11 (+3)

19% more capital invested

Capital invested by funds: $5.53B → $6.59B (+$1.06B)

5% more funds holding

Funds holding: 463 → 484 (+21)

0.35% less ownership

Funds ownership: 16.02% → 15.67% (-0.35%)

15% less repeat investments, than reductions

Existing positions increased: 149 | Existing positions reduced: 176

Holders
484
Holders Change
+21
Holders Change %
+4.54%
% of All Funds
12.07%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.27%
New
64
Increased
149
Reduced
176
Closed
38
Calls
$45.5M
Puts
$30.1M
Net Calls
+$15.4M
Net Calls Change
+$23.4M

Top Buyers

1
Fisher Asset Management
Fisher Asset Management
Washington
+$53.8M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$42.7M
3
F
Folketrygdfondet
Norway
+$32.4M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$24.2M
5
RRAM
River Road Asset Management
Kentucky
+$22.8M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$116M
2
SBAM
Santa Barbara Asset Management
California
-$79.5M
3
Millennium Management
Millennium Management
New York
-$68.3M
4
Bank of America
Bank of America
North Carolina
-$45.2M
5
CGT
Capital Guardian Trust
California
-$42.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
KP
351
Keel Point
Alabama
$289K +$969 +48 +0.4%
RMDI
352
R.M. Davis Inc
Maine
$281K -$73.7K -3,650 -22%
ASN
353
Advisory Services Network
Georgia
$277K +$111K +5,520 +75%
BFS
354
Bradley Foster & Sargent
Connecticut
$275K +$259K +12,842 New
BCB
355
Brian C. Broderick
$266K -$12.7K -630 -5%
GD
356
Grandfield & Dodd
New York
$265K – – –
ECM
357
ETrade Capital Management
Virginia
$263K -$1.6M -79,200 -87%
NAM
358
NTV Asset Management
West Virginia
$257K -$40.4K -2,000 -14%
CCM
359
Carderock Capital Management
Maryland
$253K -$44.7K -2,216 -16%
BSB
360
Bangor Savings Bank
Maine
$245K +$230K +11,422 New
NBG
361
Nancy B. Gardiner
$242K -$18.2K -900 -7%
S
362
SignatureFD
Georgia
$233K -$50.9K -2,520 -19%
FTUS
363
Flow Traders U.S.
New York
$233K +$219K +10,874 New
EFS
364
Essex Financial Services
Connecticut
$233K +$219K +10,876 New
MWAC
365
Mariner Wealth Advisors (Cincinnati)
Ohio
$232K +$218K +10,800 New
BHB
366
Bank Hapoalim BM
Israel
$232K +$219K +10,840 New
HIC
367
Holderness Investments Company
North Carolina
$229K +$216K +10,700 New
CB
368
Commerce Bank
Missouri
$226K +$212K +10,512 New
AAP
369
Arax Advisory Partners
Colorado
$223K +$12.5K +618 +6%
SCM
370
Schnieders Capital Management
California
$223K +$210K +10,394 New
BCM
371
BTC Capital Management
Iowa
$221K +$207K +10,276 New
CAS
372
Cue Advisory Services
Arizona
$220K +$207K +10,280 New
AP
373
Atwood & Palmer
Missouri
$217K -$1.31M -64,784 -87%
CWM
374
Cornerstone Wealth Management
Missouri
$216K +$207K +10,240 New
BP
375
Ballentine Partners
Massachusetts
$216K +$214K +10,600 New
13 14
15
16 17

NVO Hedge Fund Activity: Q2 2017 in Review

484 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q2 2017, worth a combined $6.59B — up 19% from $5.53B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new NVO positions and 38 closed out — a net gain of 26 holders — while 149 added to existing stakes and 176 trimmed.

The largest buyer was Fisher Asset Management, adding an estimated $53.8M. The largest seller was Renaissance Technologies, cutting an estimated $116M.

  • 484 institutional investors held Novo Nordisk (NVO) as of Q2 2017, up from 463 in Q1 2017.
  • Funds reported $6.59B of Novo Nordisk stock for Q2 2017, up 19% quarter-over-quarter.
  • 64 funds opened new Novo Nordisk positions in Q2 2017 and 38 closed out, a net change of +26 holders.
  • The largest Novo Nordisk buyer in Q2 2017 was Fisher Asset Management, an estimated $53.8M added.
  • The largest Novo Nordisk seller in Q2 2017 was Renaissance Technologies, an estimated $116M sold.

Based on aggregated 13F filings for Q2 2017.